BNTC

Q: What is the price of Benitec Biopharma (BNTC) today?

The price of Benitec Biopharma (BNTC) today is $ 12.55, with return of -3.39% compared to the last year. The price of Benitec Biopharma (BNTC) started the year trading around $ 13.47 and today it is at $ 12.55. Follow the real-time price chart, the historical price of Benitec Biopharma (BNTC) and international markets.

Q: When does Benitec Biopharma (BNTC) pay dividends?

Benitec Biopharma (BNTC) did not distribute dividends in the last year.

Q: Is Benitec Biopharma (BNTC) worth it?

Currently, Benitec Biopharma (BNTC) is priced at $ 12.55, with a P/E of -11.27%, representing a deviation of -622% from its historical average P/E. In the last year, the stock showed a variation of -3.39 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -3.39%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Benitec Biopharma (BNTC) stock?

Investing in stocks of Benitec Biopharma (BNTC) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Benitec Biopharma (BNTC) yield today?

The yield of Benitec Biopharma (BNTC) was 3.55% in the last month, -3.39% in the last year and -77.83% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Benitec Biopharma (BNTC) today, the total investment would be $ 1,255.00, based on the current price of $ 12.55.If past performance were to repeat, the return on your investment would be:In 1 year: $ 1,212.46In 5 years: $ 278.23In 10 years: $ 35.01It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Benitec Biopharma Inc.

Price

$ 12.55

return (12m)

-3.39%

p/e

-11.27

p/bv

2.78

DIVIDEND YIELD

0.00%

BNTC price

BNTC

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BNTC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.55%

3 months

-5.78%

1 year

-3.39%

2 years

156.65%

5 years

-77.83%

10 years

-97.21%

Fundamentals BNTC

review the fundamentals of Benitec Biopharma shares

P/E

-11.27

Sector: -3.82 Industry: -3.82

P/S (PSR)

Sector: -4.00 Industry: -4.00

P/BV

2.78

Sector: 1.96 Industry: 1.96

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-24.28%

Sector: -65.08% Industry: -65.08%

ROE

-24.71%

Sector: -67.53% Industry: -67.53%

ROIC

-2,771.00%

Sector: -1,295.93% Industry: -1,295.93%

NET MARGIN

0.00%

Sector: -41.04% Industry: -41.04%

GROSS MARGIN

0.00%

Sector: 38.62% Industry: 38.62%

OPERATING MARGIN

0.00%

Sector: -41.08% Industry: -41.08%

EV/EBITDA

-10.41

Sector: -3.78 Industry: -3.78

EV/EBIT

-10.32

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

2.74

Sector: 1.42 Industry: 1.42

BVPS

4.07

Sector: 1.76 Industry: 1.76

EPS

-1.01

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.98

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.02

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

21.11%

Sector: - Industry: -

Fundamentals BNTC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.49	7.27	33.81%	1.63%	$ 576.06 B	28.46%
PFE	19.79	1.65	8.35%	6.36%	$ 153.81 B	12.42%
ABBV	96.21	0.00	0.00%	2.89%	$ 406.60 B	6.91%
NVO	10.94	5.63	51.50%	4.37%	$ 171.33 B	33.05%
MRK	15.74	0.00	0.00%	2.83%	$ 287.39 B	28.08%
AZN	29.15	6.12	20.99%	1.63%	$ 298.03 B	17.41%
GILD	21.01	7.90	37.62%	2.20%	$ 178.76 B	28.90%
BMY	17.40	-3.61	-20.72%	4.13%	$ 122.75 B	14.64%
ZTS	19.90	15.97	80.25%	1.67%	$ 53.19 B	28.23%
REGN	17.37	2.50	14.41%	0.59%	$ 78.27 B	31.41%
HALO	25.09	162.87	649.21%	0.00%	$ 7.95 B	22.69%
AMGN	25.83	23.00	89.06%	2.61%	$ 199.18 B	20.98%
MCK	26.05	-1,142.11	-4,383.84%	0.33%	$ 113.07 B	1.09%
VRTX	29.34	6.21	21.18%	0.00%	$ 116.00 B	32.94%
CAH	30.92	-19.04	-61.56%	0.94%	$ 51.40 B	0.68%
ADMA	17.56	8.53	48.57%	0.00%	$ 3.68 B	42.87%
BIIB	21.02	1.49	7.08%	0.00%	$ 27.18 B	13.07%
HRMY	10.18	1.86	18.24%	0.00%	$ 1.61 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BNTC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/04/2018	06/08/2018	0,73950000

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

7 years

Founded: 2019

2012

Time since IPO - 14 years

14

Employees

The Company Benitec Biopharma Inc. (United States), is listed on Nasdaq with a market value of $ 521.64 Millions, having an equity of $ 187.36 Millions.

With a total of 14 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -46.30 Millions.

As for its main indicators, the Company has a P/E ratio of -11.27, a P/BV ratio of 2.78 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BNTC.

Market cap

$ 521.64 Millions

Net worth

$ 187.36 Millions

US$ 187,360,000.00

Assets

$ 190.68 Millions

US$ 190,680,000.00

Total Shares Outstanding

46.00 Millions

46,000,000

Average Daily Trading Volume

$ 161.78 Thousand

US$ 161,780.68

Sector

Health Care

Industry

Biotechnology

BNTC

BNTC revenue and profits

Financial Results BNTC

DRAG THE FRAME TO SEE MORE DATA

BNTC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 942.16 43,73% (12M)

P/E

26.05

0.33%

ROE

-4,383.84%

P/BV

-1,142.11

CAH - Cardinal Health

$ 222.28 82,04% (12M)

P/E

30.92

0.94%

ROE

-61.56%

P/BV

-19.04

JNJ - Johnson & Johnson

$ 242.59 48,69% (12M)

P/E

21.49

1.63%

ROE

33.81%

P/BV

7.27

PFE - Pfizer

$ 26.81 7,94% (12M)

P/E

19.79

6.36%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 227.45 9,32% (12M)

P/E

96.21

2.89%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 117.11 28,54% (12M)

P/E

15.74

2.83%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 194.95 35,56% (12M)

P/E

29.15

1.63%

ROE

20.99%

P/BV

6.12

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 942.16 43,73% (12 M)

P/L

26.05

0.33%

ROE

-4,383.84%

P/VP

-1,142.11

CAH - Cardinal Health

$ 222.28 82,04% (12 M)

P/L

30.92

0.94%

ROE

-61.56%

P/VP

-19.04

JNJ - Johnson & Johnson

$ 242.59 48,69% (12 M)

P/L

21.49

1.63%

ROE

33.81%

P/VP

7.27

PFE - Pfizer

$ 26.81 7,94% (12 M)

P/L

19.79

6.36%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 227.45 9,32% (12 M)

P/L

96.21

2.89%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 117.11 28,54% (12 M)

P/L

15.74

2.83%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 194.95 35,56% (12 M)

P/L

29.15

1.63%

ROE

20.99%

P/VP

6.12

Frequently Asked Questions

What is the price of Benitec Biopharma (BNTC) today?

The price of Benitec Biopharma (BNTC) today is $ 12.55, with return of -3.39% compared to the last year. The price of Benitec Biopharma (BNTC) started the year trading around $ 13.47 and today it is at $ 12.55. Follow the real-time price chart, the historical price of Benitec Biopharma (BNTC) and international markets.

When does Benitec Biopharma (BNTC) pay dividends?

Benitec Biopharma (BNTC) did not distribute dividends in the last year.

Is Benitec Biopharma (BNTC) worth it?

Currently, Benitec Biopharma (BNTC) is priced at $ 12.55, with a P/E of -11.27%, representing a deviation of -622% from its historical average P/E. In the last year, the stock showed a variation of -3.39 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -3.39%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Benitec Biopharma (BNTC) stock?

Investing in stocks of Benitec Biopharma (BNTC) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Benitec Biopharma (BNTC) yield today?

The yield of Benitec Biopharma (BNTC) was 3.55% in the last month, -3.39% in the last year and -77.83% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Benitec Biopharma (BNTC) today, the total investment would be $ 1,255.00, based on the current price of $ 12.55.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 1,212.46
In 5 years: $ 278.23
In 10 years: $ 35.01

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BNTC

Benitec Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BNTC

review the fundamentals of Benitec Biopharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

United States

7 years

2012

14

PROFIT X PRICE BNTC

Financial Results BNTC

BNTC cash flow

Asset, Revenue and Profit Growth - BNTC

BNTC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions